What this covers

This is an interview in which David Perlmutter talks with Dale Bredesen about Bredesen's book The End of Alzheimer's. The conversation begins with a historical frame. Twentieth-century medicine succeeded against infectious disease, but today's patients mostly face chronic, multicausal illness. Bredesen calls the habit of treating these with single-target drugs a Checkers Strategy for a Chess Match. Both men point to the record of anti-amyloid trials and of approved Alzheimer's drugs, which they say do not change the course of the disease. Perlmutter offers the alternative of magic buckshot in place of a silver bullet.

The middle of the interview covers the mechanisms Bredesen proposes. He treats amyloid-beta (Aβ)) as a protective, antimicrobial response, citing work by Rudy Tanzi and Robert Moir, and he frames the disease as a reaction to chronic inflammation, trophic loss, and toxic binding. He describes a balance between synaptic plasticity and synaptic atrophy, steered by how amyloid precursor protein is cleaved. He says the 36 factors in his protocol all feed that balance, which then reinforces itself in one direction or the other. The APOE4 discussion is one of the more contested turns: Bredesen cites an indigenous South American population in which carriers with heavy parasitic load kept their cognition, and the two speakers read the gene as an adaptation to pathogens rather than a plain risk factor.

The later part turns practical. Bredesen discusses sleep apnea, which he says goes undiagnosed in about 70% of people, along with upper airway resistance syndrome and periodic leg movements. He also covers vitamin D thresholds and receptor variants, and the temporal and parietal glucose hypometabolism seen on PET scans. He mentions published hippocampal volume and neuropsychological outcomes, and he says monotherapy can have a place only inside the wider program. He closes by raising the open question of whether chronic brain pathogens should be targeted through immune education.

Sharpest takeaway

Alzheimer's disease is not an incurable condition but rather a reversible protective response to multiple systemic factors (inflammation, trophic loss, toxic burden, pathogens); treating it requires a multi-modal 'magic buckshot' protocol addressing all contributing factors rather than seeking a single pharmaceutical magic bullet.

  • Conventional single-drug approaches to Alzheimer's have failed across billions in research spending because they ignore the disease's multi-factorial root causes
  • Dr. Bredesen has documented reversal of cognitive decline in over 1,000 patients by simultaneously addressing 36+ contributing factors including diet, exercise, sleep, infections, and metabolic status
  • Beta-amyloid is a protective antimicrobial response, not the primary pathology; removing it without addressing what triggered its production yields no benefit

The claims · ranked41 claims · weighted by value

This asset isn't compiled yet

You're seeing its claims, ranked. Compile it to build the argument threads, weight them, and check each claim against your library — the full view.

0.78

Twentieth-century medicine's primary success was conquering infectious illnesses through Public Health and antibiotics, but modern patients now predominantly face complex chronic illnesses (Alzheimer's, cancer, cardiovascular disease) that require different approaches than the reductionist strategies that worked against infections.

causalhigh valueestablishednovelty 1/4durability 4/4· Dale Bredesen

“the goal of a the entire success of twentieth-century medicine of course was mainly about getting rid of a lot of the infectious illnesses triumphing over the infectious illnesses with a combination of Public Health and antibiotics the problem of course is that we are now all pretty much to a 1 dealing with complex chronic illnesses whether you talk about Alzheimer's or other neurodegenerative diseases cancer cardiovascular disease so forth and so on”

0.77

Research demonstrates that individuals carrying the APOE4 allele (the so-called 'Alzheimer's gene') in a certain indigenous South American population had preserved cognitive function and were protective when accompanied by high parasitic load, contradicting the Western understanding that APOE4 uniformly increases Alzheimer's risk.

factualhigh valuecontestednovelty 3/4durability 3/4· Dale Bredesen

“a publication came out that demonstrated that individuals with the so-called Alzheimer's gene are carrying the apoe4 allele which we have all believed conferred significant increased risk as it does in Western cultures was actually protective in concert with high parasitic load in a certain indigenous group of individuals living in South America in other words these are people who had preserved cognitive function carried the Al's so-called Alzheimer's gene and were had a much what we call yo cynical account so a surrogate marker for high level of parasites”

0.75

The interplay between infectious agents and human genomes has been going on for an extremely long time evolutionarily, suggesting that genetic variants like APOE4 are not simply disease risk factors but adaptive responses to historical pathogenic pressure.

causalhigh valuecontestednovelty 2/4durability 4/4· David Perlmutter

“I think it sort of again reinforces the interplay between infectious agents and our genomes that has been going on an awful long time so I mean I think your comments about organisms and the brain are certainly well taken”

0.73

Alzheimer's disease is fundamentally a protective response to three distinct threats: chronic inflammation, trophic loss (loss of growth factors), and toxic binding; beta-amyloid is the brain's protective mechanism against these threats, not the primary pathology.

causalhigh valuecontestednovelty 3/4durability 3/4· Dale Bredesen

“we spent 30 years in the lab looking at what it actually tries this process and so we're coming specifically from a test tube to say what actually drives when you get neuro degeneration that we call Alzheimer's it's really a protective response that's a big surprise it's a protective response to three fundamentally different things as you know anything with chronic inflammation anything with trophic loss and anything with toxic binding the amyloid is there as a protection”

0.73

Dr. Dale Bredesen has documented reversal of Alzheimer's disease in a number of patients, which is unprecedented and monumental.

factualhigh valuecontestednovelty 3/4durability 3/4· David Perlmutter

“dr. Bredesen has published his work and has now been able to reverse Alzheimers in a number of patients which is unprecedented it's monumental”

0.70

The 36 factors in Bredesen's protocol all feed into the synaptic plasticity/clasticity balance, and this balance self-reinforces—creating either a positive 'snowball rolling downhill' toward cognitive preservation or a negative one toward decline.

causalhigh valuecontestednovelty 3/4durability 3/4· Dr. Dale Bredesen

“if you look at all the things that feed into that that's where the 36:6 things came from they feed into this beautiful balance and then what's interesting is this balance will actually accentuate itself which is where you is where we believe prions come from so the idea here is you have like a snowball ruling down Hill effect either you're going to be making this the synaptic plastic activity or synaptic plastic activity”

0.69

Current FDA-approved medications marketed to treat Alzheimer's disease do nothing to change the ultimate course of the disease progression that Alzheimer's patients experience.

factualhigh valueestablishednovelty 1/4durability 3/4· David Perlmutter

“we in the field of neurology have pretty well accepted over the years that there really isn't anything that has any meaning in terms of being therapeutically effective in dealing with Alzheimer's disease even recognizing that certain medications are marketed to so-called treat Alzheimer's the reality is that these medications that are sold and patients are taking do nothing to change the ultimate course of events that analysis patient will experience”

0.69

Vitamin D receptor (VDR) genetic variants (SNPs) are found in specific mutations in some Alzheimer's patients and constitute a genetic risk factor for Alzheimer's disease.

factualhigh valueestablishednovelty 1/4durability 3/4· Dale Bredesen

“you alluded to the vitamin D receptor has specific mutations in some people with Alzheimer's so it is a risk factor for Alzheimer's the vitamin D receptor snips”

0.69

Sleep apnea impacts Alzheimer's risk through multiple pathways: hypoxia (reduced oxygen), hypercarbia (elevated carbon dioxide), sympathetic activation (adrenaline surges causing repeated arousal), all of which have toxic effects on the brain and disrupt the signaling balance critical for synaptic plasticity.

causalhigh valueestablishednovelty 1/4durability 3/4· Dale Bredesen

“sleep apnea is an important contributor again it impacts on the same signaling it impacts because of the hypoxia it impacts because essentially having a toxic effect the increase in carbon dioxide etc so you and of course the increase in adrenaline you're now jolting yourself back away repeatedly”

0.69

The public is conditioned to expect a magic pill or silver bullet treatment for chronic diseases (high blood pressure, elevated blood glucose), but this expectation has failed catastrophically for Alzheimer's.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. David Perlmutter

“our viewers people are generally used to the fact that there is a magic pill a Silver Bullet to treat the blood pressure or the elevated blood sugar or whatever it may be and you know that has failed miserably as it relates to Alzheimer's”

0.68

Alzheimer's disease should be approached not with a single 'magic bullet' pharmaceutical intervention, but with 'magic buckshot'—multiple simultaneous interventions targeting different entry points, because Alzheimer's has multiple factors involved in its causation.

normativehigh valuecontestednovelty 2/4durability 3/4· David Perlmutter

“dr. Bredesen has looked upon the issue from a different perspective and that is not by trying to find one magic bullet but as dr. Bredesen talks about magic buckshot and that is using multiple entry points to really come at this disease that has multiple factors involved with it”

0.68

Medical practice has historically used a 'checkers strategy for a chess match'—applying reductionist single-intervention approaches (monotherapy) to complex multicausal diseases, which has failed to produce meaningful outcomes.

causalhigh valuecontestednovelty 2/4durability 3/4· Dale Bredesen

“we have continued to use the old idea of let's collect very tiny data sets and let's try to get a mono therapy that impinges on this disease and the problem is it has not worked”

0.68

Bredesen has identified two opposing synaptic processes: synaptic plasticity (formation of new neural connections) and synaptic atrophy or 'synaptic classic activity' (regression and death of neural connections); these processes are governed by amyloid precursor protein (APP) cleavage, which can be directed in either direction.

factualhigh valuecontestednovelty 2/4durability 3/4· Dale Bredesen

“we were studying the basic molecular mechanisms underlying neuro degeneration and what we found is that amyloid precursor protein a PP could literally be cleaved to same signal in two different directions it could either make neurites and make synapses so synaptic blastic activity or it could literally mediate pulling back and ultimately killing the cell inducing a mitosis so literally synaptic classic activity”

0.66

The question of whether chronic pathogens and brain microbiota alterations should be eradicated through immune system education (similar to cancer immunotherapy) is an emerging frontier in Alzheimer's treatment.

normativehigh valuecontestednovelty 3/4durability 3/4· Dr. Dale Bredesen

“we need to eradicate those and one of the big questions is should we be doing it by things like educating the immune system the way we are now doing to tumors do we need to do that for Alzheimer's as well do we need to change the microbiome in the brain the sinuses and the gut”

0.63

Billions of dollars have been spent attempting to remove beta-amyloid from Alzheimer's brains without success, and this failure is now running into additional billions despite trials attempting earlier and earlier interventions.

factualhigh valueestablishednovelty 0/4durability 3/4· Dale Bredesen

“removing the amyloid without removing the inducers of the amyloid is failing time and time and time again and it's now running into the billions of dollars as you said spent on this without any significant success so people keep saying well let's try to go earlier earlier earlier”

0.63

Poor glucose utilization is visible on PET scans specifically in the temporal and parietal regions of the brain (appearing as two L-shaped areas) in both Alzheimer's patients and pre-Alzheimer's (cognitive decline) patients.

factualhigh valueestablishednovelty 0/4durability 3/4· Dale Bredesen

“you can look at PET scans and show specifically that there is poor glucose utilization in the temporal and parietal regions literally it looks like two L's in the temporal and parietal regions in someone not only with Alzheimer's but with pre Alzheimer's as well”

0.63

Vitamin D deficiency or suboptimality is likely in anyone who lives indoors or is consistently covered/clothed, creating widespread Vitamin D insufficiency in modern populations.

factualhigh valueestablishednovelty 0/4durability 3/4· Dale Bredesen

“if you if you live indoors or you we're closed then you're likely to be vitamin D deficient or suboptimal at least”

0.63

Sleep is one of the most underappreciated factors in cognitive health; 70% of people with sleep apnea go undiagnosed throughout their lifetimes, meaning sleep disorders are both common and frequently undetected.

factualhigh valueestablishednovelty 0/4durability 3/4· Dale Bredesen

“sleep is I think one of the most underappreciated things and so many people as you know seventy percent of people who have sleep apnea go undiagnosed during their lifetimes”

0.62

Cholinesterase inhibitor drugs (still sold to treat Alzheimer's) were designed to increase acetylcholine availability based on the hypothesis that acetylcholine deficiency was the primary problem; however, this is 'multiple steps down the line' in the causal chain—the true problem is that the brain is starting to contract and lose functionality ('downsizing').

causalhigh valuecontestednovelty 1/4durability 3/4· David Perlmutter

“Alzheimer's drugs as if they really were are not getting at the problem main drugs designed to increase the availability of a chemical called acetylcholine which was found to be the probably did in the Alzheimer's brain in these cholinesterase inhibitor drugs that are still sold that's not the cause that's the that's multiple steps down the line when the brain is starting to contract and lose its functionality or a term that you use which is downsizing”

0.62

Lower vitamin D levels are associated with cognitive decline and Alzheimer's disease; multiple sclerosis research demonstrates that improvement requires vitamin D levels above 50 nanograms per milliliter, contradicting the older standard that 20-25 ng/mL is sufficient.

factualhigh valuecontestednovelty 1/4durability 3/4· Dale Bredesen

“if you look at vitamin D level lower vitamin D level is associated with cognitive decline and Alzheimer's disease as you mentioned so this is in multiple sclerosis and autism and as in as you noted in the multiple sclerosis trial you really had to get above 50 nanograms per mil to see an improvement with the MS so the old idea that 20 or 25 is good enough is simply not correct”

0.62

Bredesen has published papers documenting changes in hippocampal volume and quantitative neuropsychological assessment scores in his Alzheimer's patients, providing objective neuroimaging and cognitive outcome measures.

factualhigh valuecontestednovelty 1/4durability 3/4· Dale Bredesen

“we've as you know published papers showing changes with hippocampal volume showing changes quantitative neuropsych assessment”

0.62

Monotherapy can be used within Bredesen's protocol as long as it is combined with the rest of the comprehensive program, not as a standalone intervention.

normativehigh valuecontestednovelty 1/4durability 3/4· Dale Bredesen

“monotherapy is not optimal fine to use it as long as you use the rest of the program”

0.62

Amyloid-beta is a 'beautiful antimicrobial agent' as demonstrated by researchers Rudy Tanzi and Robert Moir from Harvard; it functions to neutralize pathogens in the brain.

factualhigh valuecontestednovelty 1/4durability 3/4· Dale Bredesen

“what is your amyloid doing there it is a beautiful antimicrobial agent as Rudy tansy and Robert Moyer from Harvard have shown beautifully over the last few years”

0.61

Upper airway resistance syndrome (UARS), periodic leg movements, and other sleep-stage disruptions are important contributors to cognitive decline and should be evaluated in anyone presenting with cognitive decline.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Dale Bredesen

“beyond sleep apnea there's also upper airway resistance syndrome so called ua r s which can also be important and self arousal with periodic leg movements a variety of things that can interrupt restorative sleep”

0.61

A 'veritable zoo' of microorganisms has been found in the brains of Alzheimer's patients, including fungi, spirochetes, oral bacteria, mold, and herpes simplex virus type 1; this suggests chronic microbial exposure is a key driver of amyloid production.

factualhigh valuecontestednovelty 2/4durability 3/4· Dale Bredesen

“when you look in the brain of a patient with Alzheimer's what has been reported fungi spirochetes oral bacteria mold the you know herpes simplex as you mentioned so this is turning out to be a veritable zoo of organisms”

0.55

Functional medicine and integrative medicine have enabled examination of multiple disease contributors that conventional medicine overlooks, providing the foundational shift necessary to move beyond single-intervention paradigms, though monotherapy can remain a component if integrated into comprehensive multi-factor programs

causalhigh valuecontestednovelty 1/4durability 3/4· Dale Bredesen

“in functional medicine and integrative medicine have taken a critical first step because they have allowed us to look at the very different contributors and as you know in Alzheimer's disease you're talking about many any different contributors it's not one thing so monotherapy is not optimal fine to use it as long as you use the rest of the program”

0.52

Bredesen notes that vitamin D connects back to the amyloid-beta discussion: vitamin D activates cathelicidin as an antimicrobial peptide, suggesting a link between vitamin D insufficiency and failure to control microbial threats that trigger innate immune amyloid production.

causalhigh valuespeaker onlynovelty 2/4durability 3/4· David Perlmutter

“it's interesting that vitamin D kind of segues back to our beta-amyloid discussion in terms of acting as a an antimicrobial peptide or activating catholicism as an antimicrobial peptide”

0.52

The sustained improvement seen in Bredesen's patients reflects that the protocol is addressing root causes of the disease, whereas temporary improvements from other therapeutics reflect symptomatic treatment while underlying causes persist.

causalhigh valuespeaker onlynovelty 1/4durability 4/4· Dale Bredesen

“you see an improvement that is sustained because you are getting at the root cause of the problem and that is so important”

0.50

Coconut oil, MCT oil, exercise, fasting, and low-carbohydrate diets combined with healthy fats have all been shown repeatedly to support brain health and provide anti-Alzheimer's effects.

factualhigh valueestablishednovelty 0/4durability 2/4· Dale Bredesen

“whether you use coconut oil or whether they use MCT oil exercise fasting a low carbohydrate diets all of these things good fats as you've emphasized so many times in your research in your books these are things that have been shown again and again to be positive for support and to be anti Alzheimer's”

0.50

Mild ketosis is achieved at 0.5 millimolar to 2-4 millimolar beta-hydroxybutyrate levels, can be easily measured and inexpensively monitored with a ketone meter, and should be targeted in Alzheimer's treatment.

normativehigh valueestablishednovelty 0/4durability 2/4· Dale Bredesen

“we want to create a mild ketosis 0.5 millimolar tufa 2 and 4 millimolar beta-hydroxybutyrate so one of the ketone bodies and certainly you can measure this very easily and inexpensively with a ketone meter”

0.48

Buckminster Fuller's principle that 'you never change things by fighting the existing reality; to change something build a new model that makes the existing model obsolete' accurately describes Bredesen's approach, which creates a paradigm replacement rather than attempting to reform conventional Alzheimer's treatment

definitionhigh valuespeaker onlynovelty 1/4durability 3/4· David Perlmutter

“you never change things by fighting the existing reality to change something build a new model that makes the existing model obsolete and that's by Buckminster Fuller that's what dr. Dale Bredesen has done he has certainly challenged the mainstream dogma of magic bullets and has really created a new reality looking at this problem Alzheimer's disease and neurodegenerative conditions in general from a very different perspective”

0.47

A neuroradiologist at a hospital where 70,000+ scans had been performed initially claimed it was 'impossible' that a patient could show an increase in hippocampal size (from 17th to 75th percentile) on Bredesen's protocol; when presented with objective confirmation, the radiologist was in the process of altering the report to show no change (35th to 35th percentile) rather than acknowledge the improvement.

factualhigh valuespeaker onlynovelty 2/4durability 3/4· Dale Bredesen

“he said that they've done over 70,000 scans at that particular hospital they had never seen this before so he said he just basically said straight out it's impossible so and I said well do you have the scans in front of you and he said yeah I said well is it are you seeing it he said yeah I said well can I get a copy so I'll take it to another computer based algorithm which we did and actually it confirmed exactly what we see what was interesting though he was in the middle of changing the report to the patient so instead of going from 17th percentile to 75th percentile it was going to read that it went from 35th to 35th and I said well how would you come up with 35th and he said well you know we would just kind of make that up so that we'd be clear that you know nothing no rules of nature have been broken”

0.45

Exercise is one of the most important factors in the protocol; spouses can directly observe whether patients with cognitive decline have exercised, as those who exercise show clear behavioral and cognitive improvement for several hours afterward, while those who miss exercise show clear worsening.

factualhigh valuespeaker onlynovelty 1/4durability 2/4· Dale Bredesen

“we've had some people where literally the spouse can tell whether the person has exercised that day we have one person who for example when she exercises she's clearly better for several hours after that when she misses her exercise she's clearly worse”

0.45

All individuals working together in the medical field should be able to make dementia and complex chronic illnesses rare, indicating this is the beginning of a historical period when these diseases can be systematically reversed rather than simply managed

forecasthigh valuespeaker onlynovelty 1/4durability 2/4· Dale Bredesen

“all of us working together should be able to make dementia and beyond that complex chronic illnesses rare and this is the beginning that we're all in we are in a part of history where we are now able to attack these complex chronic illnesses successfully for the first time”

0.39

Some individuals remain skeptical of Bredesen's claims of Alzheimer's reversal, but Bredesen proposes comparing outcomes: line up people who improved on other programs versus those improved on his protocol, and ask the patients directly what happened, suggesting that personal testimony constitutes valid evidence

normativehigh valuespeaker onlynovelty 1/4durability 2/4· Dale Bredesen

“we've had the occasional person who will say I simply don't believe this and so my argument usually is look line up to people that that you've made better with another program and we'll line up the people that are better on this program and let's talk to these people let's let's ask them what's actually happened”

0.19

A documentary film following Alzheimer's patients through the protocol is in production and expected to premiere in spring; it documents the problems patients faced, how those problems impact families and lives, and how improvements manifested when patients implemented the protocol.

factualspeaker onlynovelty 0/4durability 1/4· Dale Bredesen

“there is a documentary film that will be coming out should be coming out in the spring there's still follow-up on some of the patients and basically following people through to look at you know what were the problems how do these how do these impact their families and their lives and then what happened when they actually went on program and as they improved how did that change their watches”

0.15

Bredesen's book 'The End of Alzheimer's' was the number-one selling book on Amazon for a day (among 8 million+ total books) and remained on the New York Times bestseller list for five weeks, indicating substantial public interest in his approach.

factualspeaker onlynovelty 0/4durability 0/4· Dale Bredesen

“we went to the number one book of the eight million plus full time for a day and Weavin we remained on New York Times bestseller list for five weeks now and Counting”

0.13

Bredesen is establishing a new Institute (in partnership with groups introduced by Perlmutter) dedicated specifically to reversing neurodegenerative illnesses (not only Alzheimer's but other neurodegenerative conditions) using computational approaches, neural exosomes, and cutting-edge methods to identify contributors and induce improvement.

factualspeaker onlynovelty 0/4durability 1/4· Dale Bredesen

“we are as you know working with a group a group that initially you introduced me to to establish the first Institute the very thing that you and I have talked about over the last few years the the need for an institute where people can come specifically for reversal of neurodegenerative illnesses not only Alzheimer's but other neurodegenerative illnesses using computational approaches using neural exosomes using everything that is at the cutting edge to induce to look at all the different contributors and to induce the first people who are actually showing improvement”

0.13

Training is being provided not only to physicians but also to health coaches, neuropsychologists, nurse practitioners, and nutritional therapists through the Institute for Functional Medicine (IFM), with sessions scheduled in Dallas, Miami, London, and four locations in the US in 2018.

factualspeaker onlynovelty 0/4durability 1/4· Dale Bredesen

“we are interacting with the Institute for functional medicine to provide training we've had a few already there was one just recently in Dallas there's one December 2nd and 3rd in Miami there should be one in April in London there will be four in 2018 in the US and probably one outside the US...not only physicians but also other practitioners health coaches as you know so important neuropsychologist nurse practitioners nutritional therapists”

0.13

Readers of End of Alzheimer's have reported multiple responses: some indicate they have been using similar interventions for years with good results; others report they will immediately implement the protocol; others seek practitioners trained in the approach

factualspeaker onlynovelty 0/4durability 1/4· Dale Bredesen

“we've had a lot of a lot of interesting emails as you can imagine and you're right we went to the number one book...we're getting a lot of responses interestingly some of them are saying we've been doing this sort of thing for a while and had good results with it up always happy to see that others are saying we're going to jump on this and start this immediately or how can we find a physician who practices this”

0.10

Perlmutter has a strong family history of Alzheimer's and underwent a sleep study, making modifications to his sleep based on the findings; this demonstrates his personal commitment to the protocol recommendations.

factualspeaker onlynovelty 0/4durability 0/4· David Perlmutter

“I have a very strong family history of Alzheimer's and as such I went ahead and had a sleep study and have made some modifications based upon that”